Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Comparative Efficacy and Safety of Probiotics, Prebiotics, and Synbiotics for Type 2 Diabetes Management: A Systematic Review and Network Meta-Analysis Publisher Pubmed



Jayedi A1, 2 ; Aletaha A3 ; Zeraattalabmotlagh S2 ; Shahinfar H4 ; Mohammadpour S2 ; Mirrafiei A2 ; Jibril AT2 ; Soltani A3 ; Shabbidar S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran
  2. 2. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran

Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews Published:2024


Abstract

Aims: To compare the effects of probiotics, prebiotics, and synbiotics for type 2 diabetes (T2D) management. Methods: We searched PubMed, Scopus, CENTRAL, and grey literature sources to December 2022 for randomized trials of the impacts of probiotics, prebiotics, or synbiotics in patients with T2D. We performed network meta-analyses with a Bayesian framework to calculate mean difference [MD] and 95 % credible interval [CrI] and rated the certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Results: 68 randomised trials were included. All results are presented in comparison to the placebo. Supplementation with probiotics (MD: -0.25 %, 95%CrI: -0.42, -0.08; GRADE = moderate) and synbiotics (MD: -0.31 %, 95%CrI: -0.61, -0.04; GRADE = very low) resulted in a trivial/unimportant decrease in glycated hemoglobin. Supplementation with probiotics (MD: -0.69 mmol/L, 95%CrI: -0.98, -0.40; GRADE = very low) and synbiotics (MD: -0.82 mmol/L, 95%CrI: -1.22, -0.43; GRADE = very low) resulted in a trivial/unimportant decrease in fasting plasma glucose. Supplementation with probiotics resulted in a small but important decrease in low-density lipoprotein cholesterol (MD: -0.19 mmol/L; 95%CrI: -0.34, -0.05; GRADE = very low). Supplementations had moderate effects on serum triglyceride (GRADE = low). Conclusions: Existing evidence is uncertain and does not support supplementation with probiotics, prebiotics, and synbiotics for T2D management. © 2023 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC)
Experts (# of related papers)
Other Related Docs
25. The Role of Probiotics on Controlling Diabetes Mellitus: An Umbrella Review, Journal of Mazandaran University of Medical Sciences (2021)
43. The Role of Probiotics in Management of Infected Diabetic Foot Ulcers, Journal of Mazandaran University of Medical Sciences (2021)
48. Diabetes Management by Probiotics: Current Knowledge and Future Perspectives, International Journal for Vitamin and Nutrition Research (2016)